首页> 外国专利> Traditional Chinese Medicine Composition for the Treatment of Diabetic Retinopathy

Traditional Chinese Medicine Composition for the Treatment of Diabetic Retinopathy

机译:治疗糖尿病性视网膜病的中药组合物

摘要

The present invention provides a traditional Chinese medicine (TCM) composition for the treatment of diabetic retinopathy, wherein the active pharmaceutical ingredients (APIs) of the said TCM composition are: Astragali Radix 10-80 parts by weight, Pseudostellariae Radix 5-30 parts by weight, Cinnamomi Ramulus 3-25 parts by weight, Angelicae Sinensis Radix 8-60 parts by weight, Notoginseng Radix ET Rhizoma 2-15 parts by weight, Dioscoreae Rhizoma 10-80 parts by weight, Salviae Miltiorrhizae Radix ET Rhizoma 10-80 parts by weight, Pheretima 2-15 parts by weight, Rehmanniae Radix 8-60 parts by weight, and Atractylodis Macrocephalae Rhizoma 8-60 parts by weight. It has been shown by clinical experiments that, the invented TCM composition has an exact efficacy in patients with macular edema and can effectively improve the patients' visual acuity and visual field and relieve ocular fundus diseases, playing an active role in alleviating macular edema.
机译:本发明提供了用于治疗糖尿病性视网膜病的中药(TCM)组合物,其中所述中药组合物的活性药物成分(API)为:黄芪(Astragali Radix) 10-80重量份, 伪卫星草根 5-30重量份,肉桂木 3-25重量份,中华, 8-60重量份,< I>三七总参 ET 根茎 2-15重量份,薯ios科 10-80重量份,丹参 ET 根茎 10-80重量份,邻苯二酚 2-15重量份,熟地黄 8-60重量份和白术大黄 8-60重量份。临床实验表明,本发明的中药组合物对黄斑水肿患者有确切的疗效,可以有效改善患者的视力和视野,减轻眼底疾病,对减轻黄斑水肿起积极作用。

著录项

  • 公开/公告号US2019038695A1

    专利类型

  • 公开/公告日2019-02-07

    原文格式PDF

  • 申请/专利权人 MING JIN;

    申请/专利号US201615759052

  • 发明设计人 MING JIN;

    申请日2016-09-09

  • 分类号A61K36/481;A61K36/36;A61K36/54;A61K36/232;A61K36/258;A61K36/894;A61K36/537;A61K36/64;A61K36/28;A61K35/62;A61P27/02;

  • 国家 US

  • 入库时间 2022-08-21 12:04:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号